Kenjiro Namikawa

68PUBLICATIONS
158CO-AUTHORS
NanomedicinePredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (68)

|Jul 07, 2026
Efficacy of Adjuvant Interferon-β Versus Observation for Resected Nail Apparatus Melanoma: A Multicenter Retrospective Study.

|May 18, 2026
Comprehensive Genomic and Transcriptomic Characterization of MTAP Loss across Advanced Solid Tumors.

|Mar 27, 2026
Docetaxel for Pembrolizumab-Refractory Recurrent Basal Cell Carcinoma.

Yoshiki Sakai, Dai Ogata, Michitoshi Kurisaki

|Mar 19, 2026
Early Mycophenolate Mofetil Combination Therapy as an Effective Approach for Immune-Related Hepatitis Induced by Immune Checkpoint Inhibitors in Patients With Solid Tumor.

Yukiko Shimoda Igawa, Tatsuya Yoshida, Jun Sato

|Mar 03, 2026
Efficacy and safety of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma in Japan: Results of the Japan Clinical Oncology Group single-arm confirmatory trial (JCOG1605).

Kohei Oashi, Dai Ogata, Masayuki Yokoyama

|Jan 21, 2026
HER2 Protein Overexpression, mRNA Expression, and DNA Amplification Across Solid Tumors: Comparison of Next-Generation Sequencing-Based Assays With Immunohistochemistry.

Michiko Nagamine, Takao Fujisawa, Naoya Sakamoto

Pageof 12

Frequent Collaborators

42 joint publications

Naoya Yamazaki

29 joint publications

Dai Ogata

25 joint publications

Eiji Nakano

7 joint publications

Shunichi Jinnai